Sapphire X Anterior Cervical Fixation System 1st Procedure Performed is Seamless

December 11, 2020

The Sapphire X Anterior Cervical Fixation System features unique integrated instrumentation and high angulation screws designed to help surgeons perform the procedure while preserving the patient’s skeletal and muscle tissue.

Beyond a smaller incision is the expectation that the streamlined integrated instrumentation will reduce procedural steps and complexity. Spinal Elements reported that the first procedure was performed.

Orthopedic surgeon John DeVine, M.D., Professor and Chief of Spine Surgery at Augusta University Medical Center in Augusta, GA, said: “My first case with Sapphire X Anterior Cervical Fixation System was seamless. The single-step insertion of both the interbody spacer and the anterior plate was so effective, that it is quite impossible to make this procedure easier than it is with this system. The plate delivery system allows me to implant the plate safely without obstructing my visibility compared to connected plate-cage systems.”

After the procedure has taken place, the low-overhang implant is designed to minimize disruption to the patient’s nearby healthy anatomy, a feature that has been shown in studies to reduce the incidence of adjacent level ossification.

Jason Blain, CEO of Spinal Elements, stated: “This first procedure with Sapphire X is an exciting step forward for the MIS Ultra suite of products. We are pleased to offer an innovative solution in the anterior cervical fixation market segment and expand our disruptive MIS Ultra procedural offering.”

Spinal Elements is a Carlsbad, California-based medical device company focused on the design, development, and commercialization of a comprehensive portfolio of systems, products, and technologies for spine surgery procedures. A leading designer, developer, manufacturer, and marketer of innovative medical devices used in spinal surgical procedures, Spinal Elements combines leading medical device technologies, biologics, and instrumentation to create positive surgical outcomes that exceed surgeon and patient expectations. Spinal Elements has built a reputation delivering innovative and differentiated technologies that enable fundamental shifts in solutions for spine surgery. The company markets a complete portfolio of advanced spinal implant technologies.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”